| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MLN2480 | CTRPv2 | pan-cancer | AAC | 0.01 | 0.9 |
| mRNA | staurosporine | CTRPv2 | pan-cancer | AAC | 0.014 | 0.9 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.0088 | 0.9 |
| mRNA | elocalcitol | CTRPv2 | pan-cancer | AAC | 0.0064 | 0.9 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | -0.0063 | 0.9 |
| mRNA | TAE684 | GDSC1000 | pan-cancer | AAC | 0.01 | 0.9 |
| mRNA | BRD-K75293299 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.9 |
| mRNA | CCT007093 | GDSC1000 | pan-cancer | AAC | 0.0062 | 0.9 |
| mRNA | Tamoxifen | GDSC1000 | pan-cancer | AAC | -0.0061 | 0.9 |
| mRNA | BRD-K35604418 | CTRPv2 | pan-cancer | AAC | 0.0066 | 0.9 |